DUBLIN--(BUSINESS WIRE)--The "Global Biochip Market 2017-2021" report has been added to Research and Markets' offering.
The global biochip market is forecast to grow at a CAGR of 17.53% during the period 2017-2021.
The report, Global Biochip Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
According to the report, one driver in the market is increase in market presence with collaboration strategy. The competition in this market is intense as the number of players is high. The players are competing among themselves based on technology and price. Apart from these two factors, another factor that differentiates these competitors from each other is their presence in the market. Players increase their market presence by collaborating with those companies that own bio-content. Research says that companies generate around 60% better results when they work in collaborations. This increases their profit margins. They collaborate with each other for R&D, financial resources, and intellectual properties.
Key vendors
- Abbott
- Agilent Technologies
- Illumina
- PerkinElmer
- Thermo Fisher Scientific
Other prominent vendors
- BioChain
- Bio-Rad Laboratories
- Cepheid
- EMD Millipore
- Fluidigm
- SuperBioChips Laboratories
- US Biomax
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market segmentation by fabrication technology
PART 06: Geographical segmentation
PART 07: Decision framework
PART 08: Drivers and challenges
PART 09: Market trends
PART 10: Vendor landscape
PART 11: Key vendor analysis
PART 12: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/c7rr29/global_biochip
